D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
ICPT holding history
Intercept Pharmaceuticals, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ICPT overviewAll 13F holders of ICPTFull Q2 2026 holdings
- Shares (Q4 2023)
- 0
- Sold out in Q4 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2023 | 0 | $0 | 0.0% | −791,335−100.0% | Sold out | Holders |
| Q3 2023 | 791,335 | $14.7M | <0.1% | +123,356+18.5% | Added | Holders |
| Q2 2023 | 667,979 | $7.39M | <0.1% | +97,954+17.2% | Added | Holders |
| Q1 2023 | 570,025 | $7.66M | <0.1% | +362,943+175.3% | Added | Holders |
| Q4 2022 | 207,082 | $2.56M | <0.1% | +177,740+605.8% | Added | Holders |
| Q3 2022 | 29,342 | $409.0K | <0.1% | +29,342 | New | Holders |
| Q1 2022 | 0 | $0 | 0.0% | −47,534−100.0% | Sold out | Holders |
| Q4 2021 | 47,534 | $774.0K | <0.1% | +10,983+30.0% | Added | Holders |
| Q3 2021 | 36,551 | $543.0K | <0.1% | +36,551 | New | Holders |
| Q2 2021 | 0 | $0 | 0.0% | −14,994−100.0% | Sold out | Holders |
| Q1 2021 | 14,994 | $346.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.